PGH Explores AI and Biotech for New Investment Opportunities

The Payments Group Holding (PGH), based in Frankfurt, has announced the identification of promising business activity fields and investment opportunities in artificial intelligence (AI) and the biotech sector. The company is pursuing ventures in AI company building, in collaboration with Softmax AI, and the development of a new radiopharmaceutical for diagnostic purposes.

A standout spin-off, Cognicare AI, caters to the growing elderly care sector, showcasing proven applications. PGH aims to capitalize on these opportunities to re-establish its position as a successful venture capital investor.

The pursuits in AI and biotech are considered additional diversification options alongside the planned acquisition of The Payments Group (TPG). If the TPG transaction terms are not favorable, PGH has positioned itself with promising alternatives to benefit from in 2026.